Lucia Torracca

ORCID: 0000-0003-2689-9440
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Cardiac Structural Anomalies and Repair
  • Cardiac and Coronary Surgery Techniques
  • Infective Endocarditis Diagnosis and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Coronary Interventions and Diagnostics
  • Aortic Disease and Treatment Approaches
  • Cardiac Imaging and Diagnostics
  • Mechanical Circulatory Support Devices
  • Cardiac tumors and thrombi
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Aortic aneurysm repair treatments
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • COVID-19 and healthcare impacts
  • Cardiovascular Function and Risk Factors
  • Cardiac Arrest and Resuscitation
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Issues in Pregnancy
  • Congenital Heart Disease Studies
  • Peripheral Artery Disease Management
  • COVID-19 Clinical Research Studies
  • Acute Myocardial Infarction Research
  • Cardiovascular and Diving-Related Complications
  • Neurofibromatosis and Schwannoma Cases

IRCCS Humanitas Research Hospital
2017-2024

Humanitas University
2017-2024

Istituti di Ricovero e Cura a Carattere Scientifico
2020-2021

Ospedali Riuniti di Ancona
2009-2017

Azienda Ospedaliero Universitaria Ospedali Riuniti
2010-2016

Angiologica (Italy)
2016

University Hospital of Bern
2014

Institute of Social and Preventive Medicine
2014

University of Bern
2014

Fundación Juan March
2014

The ESC/EACTS Guidelines represent the views of ESC and EACTS were produced after careful consideration scientific medical knowledge evidence available at time their dating.The are not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals encouraged take ESC/ fully into account when exercising...

10.1093/eurheartj/ehu278 article EN European Heart Journal 2014-08-29

10.1093/ejcts/ezu366 article ES European Journal of Cardio-Thoracic Surgery 2014-08-31

Table 1. Classes of recommendation Table 2. Levels evidence Table 3. Estimated fetal and maternal effective doses for various diagnostic interventional radiology procedures Table 4. Predictors cardiovascular events risk score from the CARPREG study Table 5. identified in congential heart diseases ZAHARA Khairy 6. Modified WHO classification risk: principles Table 7. application Table 8. Maternal predictors neonatal women with disease Table 9. General recommendations Table 10....

10.1093/eurheartj/ehr218 article EN European Heart Journal 2011-08-26

Radiofrequency ablation for atrial fibrillation is becoming widely practiced.Two patients undergoing circumferential pulmonary vein in different centers developed symptoms compatible with endocarditis 3 to 5 days after the procedure. Their clinical condition deteriorated rapidly, and both suffered multiple gaseous and/or septic embolic events causing cerebral myocardial damage. One patient survived emergency cardiac esophageal surgery; other died of extensive systemic embolization. An...

10.1161/01.cir.0000131866.44650.46 article EN Circulation 2004-05-25

The prospective, multinational, randomized Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial was designed to assess the optimal revascularization strategy between percutaneous coronary intervention (PCI) artery bypass grafting (CABG), for patients with left main (LM) and/or 3-vessel disease.This observational hypothesis-generating analysis reports results of a prespecified powered subgroup 705 who had LM disease among 1800 de novo PCI...

10.1161/circulationaha.109.899211 article EN Circulation 2010-06-08
Sigrun Halvorsen Julinda Mehilli Salvatore Cassese Trygve S. Hall Magdy Abdelhamid and 95 more Emanuele Barbato Stefan De Hert Ingrid de Laval Tobias Geisler Lynne Hinterbuchner Borja Ibáñez Radosław Lenarczyk Ulrich Mansmann Paul McGreavy Christian Mueller Claudio Muneretto Alexander Niessner Tatjana Potpara Arsen Ristić Leyla Elif Sade Henrik Schirmer Stefanie Schüpke Henrik Sillesen Helge Skulstad Lucia Torracca Oktay Tutarel Peter van der Meer Wojciech Wojakowski Kai Zacharowski Juhani Knuuti Steen Dalby Kristensen Victor Aboyans Ingo Ahrens Sotiris Antoniou Riccardo Asteggiano Dan Atar Andreas Baumbach Helmut Baumgartner Michael Böhm Michael A. Borger Héctor Bueno Jelena Čelutkienė Alaide Chieffo Maya Cikes Harald Darius Victoria Delgado P.J. Devereaux David Duncker Volkmar Falk Laurent Fauchier Gilbert Habib David Hasdai Kurt Huber Bernard Iung Tiny Jaarsma А. О. Конради Konstantinos C. Koskinas Dipak Kotecha Ulf Landmesser Basil S. Lewis Aleš Linhart Maja Lisa Løchen Michael Mæng Stéphane Manzo‐Silberman Richard Mindham Lis Neubeck Jens Cosedis Nielsen Steffen E. Petersen Eva Prescott Amina Rakisheva Antti Saraste Dirk Sibbing Jolanta M. Siller‐Matula Marta Sitges Ivan Stanković Robert F. Storey Jurriën M. ten Berg Matthias Thielmann Rhian M. Touyz Mohammed Amine Bouzid Hamayak Sisakian Bernhard Metzler Vadim Shumavets Agnès Pasquet Elnur Smajić Maria Milanova Boško Škorić Maria Karakyriou Hana Skalická Michael Mæng Bassem Abd Elhamid Arno Ruusalepp Kati Valtola Ariel Cohen Archil Chukhrukidze Ilka Ott Nikos Kafkas Zoltán Járai Þórdís Jóna Hrafnkelsdóttir Patricia Campbell

All experts involved in

10.1093/eurheartj/ehac270 article EN European Heart Journal 2022-08-26

Repair of mitral regurgitation (MR) is more demanding in case prolapse the anterior leaflet, posterior leaflet with calcified annulus, or both leaflets. We evaluated a repair which consists anchoring free edge prolapsing to corresponding facing leaflet: 'edge-to-edge' (E-to-E) technique. The correction results double orifice valve when middle portion and smaller close commissure.Out 432 patients MR submitted between January 1991 September 1997, 121 (mean age 56 +/- 15.8 years) underwent...

10.1016/s1010-7940(98)00014-1 article EN European Journal of Cardio-Thoracic Surgery 1998-03-01

Niniejsze wytyczne ESC opublikowano wyłącznie do użytku prywatnego i edukacyjnego.Nie zezwala się na wykorzystywanie w celach komercyjnych.Żadna część wytycznych nie może być tłumaczona ani kopiowana żadnej postaci bez wcześniejszej pisemnej zgody ESC.Pozwolenie można uzyskać, zwracając z

10.5603/kp.2014.0224 article PL Kardiologia Polska 2014-12-12

Acute coronary syndromes Bare-metal stents Coronary artery bypass grafting disease Drug-eluting EuroSCORE Guidelines Heart Team Myocardial infarction ischaemia revascularization Medical therapy Percutaneous intervention Recommendation Revascularisation Risk stratification Stents Stable angina ST-segment elevation myocardial SYNTAX score

10.4244/eijy14m09_01 article EN EuroIntervention 2015-01-01

Inflammation is a key component of cardiac disease, with macrophages and T lymphocytes mediating essential roles in the progression to heart failure. Nonetheless, little insight exists on other immune subsets involved cardiotoxic response.Here, we used single-cell RNA sequencing map composition standard murine nonischemic, pressure-overload failure model. By focusing our analysis CD45+ cells, obtained higher resolution identification cell heart, at early late stages disease controls. We then...

10.1161/circulationaha.119.041694 article EN Circulation 2019-10-30

Abstract Transcatheter aortic valve implantation (TAVI) is effective in older patients with symptomatic severe stenosis, while the indication has recently broadened to younger at lower risk. Although thromboembolic and bleeding complications after TAVI have decreased over time, such adverse events are still common. The recommendations of latest 2017 ESC/EACTS Guidelines for management valvular heart disease on antithrombotic therapy undergoing mostly based expert opinion. Based recent...

10.1093/eurheartj/ehab196 article EN European Heart Journal 2021-03-17

From January 1987 to July 1994, 299 consecutive patients ranging from 4 80 years of age underwent mitral repair for pure valve insufficiency due degenerative disease (59%), rheumatic (23%), endocarditis (12%) or ischemic heart (6%). During the initial period, a variety reparative methods were used following principles originally described by Carpentier. More recently, in our institution other surgical techniques have been introduced: specifically, prolapse anterior leaflet was corrected...

10.1016/s1010-7940(05)80107-1 article EN European Journal of Cardio-Thoracic Surgery 1995-01-01

Background— The aim of this study was to assess the results mitral valve (MV) repair in functional regurgitation because end-stage dilated cardiomyopathy (DCM). Methods and Results— Seventy-seven patients with idiopathic (26 patients) or ischemic (51 DCM underwent MV for (3 4+/4+). Fifty-eight (75.3%) were New York Heart Association class III, 19 (24.6%) IV. In 23 (29.8%) a coaptation depth <1 cm, an isolated undersized annuloplasty used. remaining 54 (70.1%), ≥1 “edge-to-edge” technique...

10.1161/circulationaha.104.525188 article EN Circulation 2005-08-30

Early studies of the Tendyne transcatheter mitral valve replacement (TMVR) showed promising results in a small selective cohort. The authors present 1-year data from currently largest commercial, real-world cohort originating investigator-initiated TENDER (Tendyne European Experience) registry. All patients registry eligible for follow-up were included. primary safety endpoint was cardiovascular mortality. Primary performance reduction regurgitation (MR) up to 1 year. Among 195 undergoing...

10.1016/j.jcin.2023.12.027 article EN cc-by КАРДИОЛОГИЯ УЗБЕКИСТАНА 2024-02-21

To assess the evolution of tricuspid regurgitation (TR) in dilated cardiomyopathy (DCM) patients submitted to mitral repair for functional (MR).Ninety-one DCM (mean age 61+/-11.3) MV (+/-tricuspid repair) MR were included. Preoperative EF was 30.9+/-6.5%, left ventricular (LV) end-diastolic volume 113+/-31.5 ml/m(2), LV end-systolic 81.8+/-26.7 > or =3+/4+. TR classified as < =1+/4+ 57 (62.6%), 2+/4+ 21 (23%) and =3+/4+ 13 (14.2%). Most NYHA class III IV. A annuloplasty associated whenever...

10.1016/j.ejcts.2008.01.011 article EN cc-by European Journal of Cardio-Thoracic Surgery 2008-02-14
Coming Soon ...